News

Blood-thinning drug predicted to save lives

21-Apr-08

A new blood-thinning drug could help to prevent tens of thousands of deaths due to blood clots.

The drug, known as Pradaxa (dabigatran etexilate), received its licence today and will become available to hospitals within weeks.

It will be used initially to prevent clots after hip and knee replacement surgery when the risk of blood clotting is high.

But the hope is that the drug will open the door to more effective treatments for thousands of other patients at risk of heart conditions and strokes.

Currently, the number of deaths linked to blood clots accounts for one in 10 of all deaths in UK hospitals.

Beverly Hunt, medical director of the UK thrombosis charity Lifeblood , said: ‘The development of new drugs to treat blood clots is terribly exciting.

‘The potential benefit to the NHS is enormous.’

sanjay.tanday@haymarket.com

Comment below and tell us what you think

Comments

STEPHEN BIRD

21/04/2008

What does 'linked to' mean? Is it that 1 in 10 Post Mortem examinations identified some degree of (asymptomatic) DVT or that there was evidence of significant clot morbidity preceeding & contributing to death?

roy evison

21/04/2008

Is Pradaxa meant or likely to replace Warfarin? What would the implications be to staff and the possible lack of monitoring?

If warfarin is so toxic and needs constant monitering then what is so wonderful about this one .i.e if warfarin makes you bleed then how can this one act in a different fashion?

Only registered users may comment. Log in now or register for a free account.

There are problems with your form submission.

Please review the errors shown below.



Forgot your password?

Quick search - use * for an abbreviated search, eg nico*

 
 

Healthcare Republic Forums

 

Nursing Professional Issues

Supporting victims of childhood sexual abuse

Health professionals can help patients recover from psychosexual trauma, writes Graham Wilmer. Read More

Rise of the GP-led health centres

As the new 'super-surgeries' open, we consider the possible opportunities for nurses. Joe Lepper rep... Read More

Career Profile - Staff nurse, eating disorders service

Daniel Brown, Roehampton, London Read More

Show all articles

Latest Clinical Articles

Abnormal uterine bleeding

Contributed by Mr Antonio V Antoniou, consultant gynaecologist and lead in minimal access surgery an... Read more

Chronic low back pain

Dr Mark Ritchie, GPSI in pain management, Morriston, Swansea Read more

Acute and sub-acute back pain

Contributed by Dr Mark Ritchie, GPSI in pain management, Morriston, Swansea Read more

Show all clinical articles

MIMS Product News

New drug - Stelara

Janssen-Cilag has launched Stelara for the treatment of moderate to severe plaque psoriasis where ot... Read more

New high-strength nicotine patch

Nicorette Invisipatch is the latest addition to the range of available nicotine replacement therapy ... Read more

Prolonged-release aspirin

Flamasacard, a prolonged-release formulation of aspirin, for secondary prophylaxis after a first cor... Read more

Jobs

 

Job of the Week